Molecular Matrix, Inc.
PrivateLast Round
Angel
Jan 11, 2018
Total Funding Raised
$855,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Molecular Matrix, Inc. operates in Healthcare & Life Sciences and is based in Rancho Cordova, California. Its latest recorded funding round was an Angel round in January 2018.
Molecular Matrix, Inc. is a biotechnology company that develops and provides solutions in bone regeneration, tissue engineering, and regenerative medicine. The company's main product is Osteo-P® BGS, a synthetic, non-mineralized bone graft substitute used in orthopedic, spine, and trauma applications to support and guide the ingrowth of new bone.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecular Matrix, Inc. Comparables
Compare Molecular Matrix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cerapedics | 85% | |
| OssDsign | 81% | |
| Bone Biologics Corporation | 78% |
For institutional investors. Book with your work email.
Molecular Matrix, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Molecular Matrix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UC Davis Health Ventures | Angel |
| Shasta Angel Group | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 39% MoM, reaching 1.6K.
- Feb 1, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
Molecular Matrix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecular Matrix, Inc.'s valuation, stock price, and market status.
Is Molecular Matrix, Inc. a public or private company?
Molecular Matrix, Inc. is a private company.
What is the current stock price of Molecular Matrix, Inc.?
Molecular Matrix, Inc. is a private company, so its shares have no public market price. Caplight tracks Molecular Matrix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecular Matrix, Inc. worth (valuation)?
Valuation information for Molecular Matrix, Inc. is not publicly available.
Can I buy Molecular Matrix, Inc. stock?
Molecular Matrix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecular Matrix, Inc.'s last funding round?
Molecular Matrix, Inc.'s most recent funding round was Angel on January 11, 2018.
Who are the main investors in Molecular Matrix, Inc.?
Key investors in Molecular Matrix, Inc. include UC Davis Health Ventures, Shasta Angel Group.
Will Molecular Matrix, Inc. IPO soon?
No public IPO plans have been announced for Molecular Matrix, Inc..
How can I track Molecular Matrix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Molecular Matrix, Inc.'s shares on secondary markets.